Wilhem Leconet

699 total citations
12 papers, 514 citations indexed

About

Wilhem Leconet is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Wilhem Leconet has authored 12 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Immunology. Recurrent topics in Wilhem Leconet's work include Monoclonal and Polyclonal Antibodies Research (5 papers), Phagocytosis and Immune Regulation (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Wilhem Leconet is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (5 papers), Phagocytosis and Immune Regulation (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Wilhem Leconet collaborates with scholars based in France, United States and Netherlands. Wilhem Leconet's co-authors include Bruno Robert, Marta Jarlier, André Pèlegrin, Christel Larbouret, Jean‐Max Pasquet, Muriel Busson, Thierry Chardès, Martine Pugnière, Nina Radosevic‐Robin and Audrey Sirvent and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes and Oncogene.

In The Last Decade

Wilhem Leconet

12 papers receiving 502 citations

Peers

Countries citing papers authored by Wilhem Leconet

Since Specialization

Citations

This map shows the geographic impact of Wilhem Leconet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wilhem Leconet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wilhem Leconet more than expected).

Fields of papers citing papers by Wilhem Leconet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wilhem Leconet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wilhem Leconet. The network helps show where Wilhem Leconet may publish in the future.

Co-authorship network of co-authors of Wilhem Leconet

This figure shows the co-authorship network connecting the top 25 collaborators of Wilhem Leconet. A scholar is included among the top collaborators of Wilhem Leconet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wilhem Leconet. Wilhem Leconet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Intra-articular delivery of full-length antibodies through the use of an in situ forming depot 2021 ·Journal of Controlled Release ·(unknown), Wilhem Leconet, Karine Toupet, (unknown), Guillaume Bossis, Marion de Toledo, Jérôme Vialaret, Christophe Hirtz, Adolfo López‐Noriega, Christian Jørgensen, Danièle Noël, Pascale Louis‐Plence, Sylvestre Grizot, Martín Villalba	9
2	Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva 2021 ·SHILAP Revista de lepidopterología ·Thomas J. Ketas, Devidas N. Chaturbhuj, (unknown), Erik Francomano, Encouse B. Golden, (unknown), Gargi Debnath, (unknown), Anila Yasmeen, (unknown), (unknown), Wilhem Leconet, Zhen Zhao, Philip J. M. Brouwer, Melissa M. Cushing, Rogier W. Sanders, Albert Cupo, Per Johan Klasse, Silvia C. Formenti, John P. Moore	80
3	Anti-PSMA/CD3 Bispecific Antibody Delivery and Antitumor Activity Using a Polymeric Depot Formulation 2018 ·Molecular Cancer Therapeutics ·Wilhem Leconet, He Liu, Ming‐Lei Guo, (unknown), (unknown), Sae Kim, (unknown), (unknown), Fang Liu, (unknown), Jaspreet S. Batra, (unknown), Sylvestre Grizot, Neil H. Bander	41
4	Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis 2016 ·Clinical Cancer Research ·Wilhem Leconet, (unknown), Stanislas du Manoir, Clément Chevalier, Audrey Sirvent, Imade Aït-Arsa, Muriel Busson, Marta Jarlier, Nina Radosevic‐Robin, Charles Theillet, Dany Chalbos, Jean‐Max Pasquet, André Pèlegrin, Christel Larbouret, Bruno Robert	87
5	Induction of PSMA and Internalization of an Anti-PSMA mAb in the Vascular Compartment 2016 ·Molecular Cancer Research ·Daniel P. Nguyen, (unknown), He Liu, Samuel Pan, Wilhem Leconet, Vincent Navarro, Ming‐Lei Guo, (unknown), Sae Kim, Marigdalia K. Ramirez‐Fort, Jaspreet S. Batra, Neil H. Bander	31
6	CBL controls a tyrosine kinase network involving AXL, SYK and LYN in nilotinib‐resistant chronic myeloid leukaemia 2015 ·The Journal of Pathology ·Romain Gioia, (unknown), Pierre‐Yves Dumas, Valérie Lagarde, Valérie Prouzet‐Mauleon, Vanessa Desplat, Audrey Sirvent, Vincent Praloran, Éric Lippert, Arnaud Villacreces, Wilhem Leconet, Bruno Robert, Isabelle Vigon, Serge Roche, François‐Xavier Mahon, Jean‐Max Pasquet	24
7	HER3 as biomarker and therapeutic target in pancreatic cancer: new insights in pertuzumab therapy in preclinical models 2014 ·Oncotarget ·(unknown), Thierry Chardès, Nadège Gaborit, Caroline Mollévi, Wilhem Leconet, Bruno Robert, Nina Radosevic‐Robin, Frédérique Penault‐Llorca, Céline Gongora, Pierre‐Emmanuel Colombo, Yassamine Lazrek, Rui Bras-Gonçalves, Ariel Savina, D. Azria, Hervé Bazin, André Pèlegrin, Christel Larbouret	38
8	Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy 2013 ·Oncogene ·Wilhem Leconet, Christel Larbouret, Thierry Chardès, (unknown), (unknown), Muriel Busson, Marta Jarlier, (unknown), Martine Pugnière, Florence Bernex, Frédérique Penault‐Llorca, Jean‐Max Pasquet, André Pèlegrin, Bruno Robert	81
9	Anti-HER3 Domain 1 and 3 Antibodies Reduce Tumor Growth by Hindering HER2/HER3 Dimerization and AKT-Induced MDM2, XIAP, and FoxO1 Phosphorylation 2013 ·Neoplasia ·Yassamine Lazrek, Olivier Dubreuil, Véronique Garambois, Nadège Gaborit, Christel Larbouret, Christophe Le Clorennec, (unknown), Wilhem Leconet, Marta Jarlier, Martine Pugnière, Nadia Vié, Bruno Robert, Céline Monnet, Khalil Bouayadi, (unknown), Philippe Mondon, André Pèlegrin, Thierry Chardès	35
10	Sorafenib Overcomes Irinotecan Resistance in Colorectal Cancer by Inhibiting the ABCG2 Drug-Efflux Pump 2013 ·Molecular Cancer Therapeutics ·Thibault Mazard, Annick Causse, J Simony, Wilhem Leconet, Nadia Vezzio-Vié, (unknown), Marta Jarlier, Alexandre Evrard, Maguy Del Rio, Eric Assénat, Pierre Martineau, Marc Ychou, Bruno Robert, Céline Gongora	43
11	Nonviral Delivery of Small Interfering RNA Into Pancreas-associated Immune Cells Prevents Autoimmune Diabetes 2012 ·Molecular Therapy ·Wilhem Leconet, Pierre Petit, Sylvie Péraldi‐Roux, Damien Bresson	15
12	Preexisting Autoantibodies Predict Efficacy of Oral Insulin to Cure Autoimmune Diabetes in Combination With Anti-CD3 2012 ·Diabetes ·Alusha A. Mamchak, (unknown), Wilhem Leconet, Yanan Zheng, Jason R. Chan, Cynthia L. Stokes, Lisl K.M. Shoda, Matthias von Herrath, Damien Bresson	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact